Effect of levocarnitine administration in patients with chronic liver disease

L-carnitine administration was reported to improve sarcopenia in patients with cirrhosis. However, the amount of evidence from previous studies is not sufficient. The present study aimed to clarify the effect of levocarnitine (L-carnitine) administration on body composition in patients with chronic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Exp Ther Med
Hlavní autoři: Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Fujiko, Kobayashi, Miki, Hirosawa, Shiori, Sugiyama, Kaede, Mitobe, Yuta, Yoshida, Toshiaki
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2020
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507016/
https://ncbi.nlm.nih.gov/pubmed/32973943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9222
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky